BioCardia Inc
NASDAQ:BCDA
BioCardia Inc
NASDAQ:BCDA
Price:
0.39861 USD
4.92%
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one
BCDA
stock under the Base Case scenario is
2.93885
USD.
Compared to the current market price of 0.39861 USD,
BioCardia Inc
is
Undervalued by 86%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BCDA
Relative Value
Base Case
2.93885
USD
Undervaluation 86%
Valuation Multiples
Multiples Across Competitors
BCDA Competitors Multiples
BioCardia Inc Competitors
BioCardia Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
BioCardia Inc
NASDAQ:BCDA
|
10.7m USD | 22.5 | -0.9 | -0.8 | -0.8 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
285.6B USD | 5.3 | 59.3 | 12.9 | 19.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
159.7B USD | 5.7 | 23.8 | 17.3 | 26 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
104.4B USD | 8 | 26.4 | 17.8 | 19.6 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
103.6B USD | 10.5 | 28.6 | 22.9 | 24 | |
| AU |
|
CSL Ltd
ASX:CSL
|
133.1B AUD | 6.2 | 35.6 | 21.6 | 26.7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
80.3B USD | 2.9 | 165.8 | 6.6 | 8.7 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
45.9B USD | 6.7 | -9.7 | -10.5 | -8.9 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
32.1B USD | 3.3 | 27.5 | 14.1 | 17.6 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.2T KRW | 18 | 73.1 | 44.7 | 61.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
